Table 1.
PMMA/CMC/PLGA constructs | Initial composition | Composition of dried sample | ||||
---|---|---|---|---|---|---|
PLGA conc. (wt%) |
CMC conc. (wt%) |
PLGA conc. (wt%) |
CMC salt conc. (wt%) |
Drug content | ||
(wt%) | mg/mL scaffold | |||||
10%PLGA-40%CMC | 10 | 40 | 9.4 | 5.7 | 1.5 | 11.2 |
15%PLGA-40%CMC | 15 | 40 | 14.1 | 5.7 | 2.3 | 16.6 |
10%PLGA-50%CMC | 10 | 50 | 9.2 | 8.3 | 1.5 | 9.1 |
15%PLGA-50%CMC | 15 | 50 | 13.8 | 8.3 | 2.2 | 13.4 |